Yale researchers have overturned a long-held assumption about fat and cancer risk, discovering that not all fats are created equal when it comes to pancreatic cancer—and some foods long celebrated as heart-healthy may actually fuel tumor growth.
The findings, published in Cancer Discovery, reveal that the type of dietary fat matters far more than total fat consumption. Scientists led by Christian Felipe Ruiz, an associate research scientist in Yale School of Medicine's Department of Genetics, and senior author Mandar Deepak Muzumdar, an associate professor at Yale Cancer Center, found that omega-3 fatty acids from fish oil can reduce pancreatic cancer development by 50%, while oleic acid—the primary fatty acid in olive oil—paradoxically accelerates tumor growth in pancreatic ductal adenocarcinoma (PDAC), the deadliest and most common form of pancreatic cancer.
The discovery matters because PDAC is ruthless. More than 65,000 people are expected to be diagnosed with PDAC in the United States this year alone, with over 50,000 deaths projected. Only about 13% of patients survive five years after diagnosis. Current treatment options remain severely limited, especially for advanced disease, making prevention strategies urgent.
To isolate which fats influence cancer development, researchers designed 12 different high-fat diets with identical calorie counts, varying only the fat source to reflect typical American eating patterns. Previous studies had taken cruder approaches, often feeding mice diets where 60% of calories came from lard—a methodology that obscured the effects of specific fatty acids. This new study changed that by examining distinct types of fats in realistic proportions.
The results astonished the team. Mice carrying genetic mutations that produce human PDAC-like disease developed tumors more rapidly on diets rich in oleic acid, a monounsaturated fatty acid found in olive oil, high-oleic safflower oil, peanuts, and lard. Ruiz notes the irony: oleic acid has been "traditionally considered a healthy type of fat for cardiovascular health." Yet in pancreatic cancer, it appears to do harm.
By contrast, polyunsaturated fatty acids (PUFAs), particularly omega-3s from fish oil, dramatically slowed cancer progression. "When we fed mice diets enriched with fish oil, we saw a 50% reduction in disease compared with mice fed a standard fat diet," Ruiz said.
The mechanism behind this protective effect involves ferroptosis, a form of programmed cell death triggered by lipid oxidation. When fatty acids integrate into cell membranes, their chemical properties determine whether cancer cells can be damaged by oxidation. PUFAs are highly prone to oxidation, making cancer cells vulnerable to ferroptosis and death. Monounsaturated fats resist oxidation, shielding cancer cells from this fatal process. As Ruiz explains: "Monounsaturated fats really protect the cancer cells from lipid oxidation. Because oxidation is reduced, they're less likely to undergo ferroptosis."
The research team observed a direct relationship: increasing the ratio of monounsaturated to polyunsaturated fats in the diet heightened disease burden, while decreasing that ratio reduced it. Notably, sex also played a role—oleic acid's cancer-promoting effects were pronounced in male mice but largely absent in females, though PUFAs protected both sexes.
These findings suggest that pancreatic cancer prevention may hinge not on eating less fat overall, but on choosing the right kinds. For millions at risk, that distinction could prove life-saving.